Dose/schedule finding study of palonosetron in sarcoma patients receiving multi-day chemotherapy with adriamycin and ifosfamide (AI).

Trial Profile

Dose/schedule finding study of palonosetron in sarcoma patients receiving multi-day chemotherapy with adriamycin and ifosfamide (AI).

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Mar 2013

At a glance

  • Drugs Palonosetron (Primary)
  • Indications Chemotherapy-induced nausea and vomiting
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Dec 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
    • 15 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 May 2011 Planned end date changed from 1 Dec 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top